|
1
|
Gorbalenya AE, Baker SC, Baric RS, De
Groot RJ, Drosten C, Gulyaeva AA, Haagmans BL, Lauber C, Leontovich
AM, et al: Coronaviridae Study Group of the International Committee
on Taxonomy of Viruses: The species Severe acute respiratory
syndrome-related coronavirus: Classifying 2019-nCoV and naming it
SARS-CoV-2. Nat Microbiol. 5:536–544. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges (Review). Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Khan M, Khan H, Khan S and Nawaz M:
Epidemiological and clinical characteristics of coronavirus disease
(COVID-19) cases at a screening clinic during the early outbreak
period: A single-centre study. J Med Microbiol. 69:1114–1123.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H,
Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and
epidemiology of 2019 novel coronavirus: Implications for virus
origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ye Q, Wang B and Mao J: The pathogenesis
and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect.
80:607–613. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen
Y, Jiang X and Li X: C-reactive protein correlates with computed
tomographic findings and predicts severe COVID-19 early. J Med
Virol. 92:856–862. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wilson PG, Thompson JC, Webb NR, de Beer
FC, King VL and Tannock LR: Serum amyloid A, but not C-reactive
protein, stimulates vascular proteoglycan synthesis in a
pro-atherogenic manner. Am J Pathol. 173:1902–1910. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vietri L, Fui A, Bergantini L,
d'Alessandro M, Cameli P, Sestini P, Rottoli P and Bargagli E:
Serum amyloid A: A potential biomarker of lung disorders. Respir
Investig. 58:21–27. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Goldenberg DM, Neville AM, Carter AC, Go
VL, Holyoke ED, Isselbacher KJ, Schein PS and Schwartz M: CEA
(carcinoembryonic antigen): Its role as a marker in the management
of cancer. J Cancer Res Clin Oncol. 101:239–242. 1981.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hao C, Zhang G and Zhang L: Serum CEA
levels in 49 different types of cancer and noncancer diseases. Prog
Mol Biol Transl Sci. 162:213–227. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu Q, Wang RS, Qu GQ, Wang YY, Liu P, Zhu
YZ, Fei G, Ren L, Zhou YW and Liu L: Gross examination report of a
COVID-19 death autopsy. Fa Yi Xue Za Zhi. 36:21–23. 2020.PubMed/NCBI View Article : Google Scholar : (In English,
Chinese).
|
|
13
|
Fahim A, Crooks MG, Wilmot R, Campbell AP,
Morice AH and Hart SP: Serum carcinoembryonic antigen correlates
with severity of idiopathic pulmonary fibrosis. Respirology.
17:1247–1252. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
WHO: World Health Organization.
Coronavirus Disease (COVID-19) Outbreak. World Health Organization,
Geneva, 2020.
|
|
15
|
Teama MA, Abdelhakam DA, Elmohamadi MA and
Badr FM: Vitamin D deficiency as a predictor of severity in
patients with COVID-19 infection. Sci Prog.
104(368504211036854)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
World Medical Association. World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. JAMA. 310:2191–2194.
2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Prokop M, van Everdingen W, van Rees
Vellinga T, Quarles van Ufford H, Stöger L, Beenen L, Geurts B,
Gietema H, Krdzalic J, Schaefer-Prokop C, et al: COVID-19
Standardized Reporting Working Group of the Dutch Radiological
Society: CO-RADS: A categorical CT assessment scheme for patients
suspected of having COVID-19-definition and evaluation. Radiology.
296:E97–E104. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Francone M, Iafrate F, Masci GM, Coco S,
Cilia F, Manganaro L, Panebianco V, Andreoli C, Colaiacomo MC,
Zingaropoli MA, et al: Chest CT score in COVID-19 patients:
Correlation with disease severity and short-term prognosis. Eur
Radiol. 30:6808–6817. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song
J, Zhao X, Huang B, Shi W, et al: A novel coronavirus from patients
with pneumonia in China. N Engl J Med. 382:727–733. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX,
Wang QZ, Sun C, Sylvia S, Rozelle S, Raat H, et al: Epidemiology,
causes, clinical manifestation and diagnosis, prevention and
control of coronavirus disease (COVID-19) during the early outbreak
period: A scoping review. Infect Dis Poverty. 9(29)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma
CL, Li SB, Wang HY, Zhang S, Gao HN, et al: Clinical findings in a
group of patients infected with the 2019 novel coronavirus
(SARS-Cov2) outside of Wuhan, China: Retrospective case series.
BMJ: Feb 19, 2020 (Epub ahead of print).
|
|
22
|
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J,
Liu L, Shan H, Lei C, Hui DS, et al: Clinical characteristics of
coronavirus disease 2019 in China. N Engl J Med. 382:1708–1720.
2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wu J, Liu J, Li S, Peng Z, Xiao Z, Wang X,
Yan R and Luo J: Detection and analysis of nucleic acid in various
biological samples of COVID-19 patients. Travel Med Infect Dis.
37(101673)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lin C, Ding Y, Xie B, Sun Z, Li X, Chen Z
and Niu M: Asymptomatic novel coronavirus pneumonia patient outside
Wuhan: The value of CT images in the course of the disease. Clin
Imaging. 63:7–9. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Vargas-Vargas M and Cortés-Rojo C:
Ferritin levels and COVID-19. Rev Panam Salud Publica.
44(e72)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yang Z, Shi J, He Z, Lu Y, Xu Q, Ye C,
Chen S, Tang B, Yin K, Lu Y, et al: Predictors for imaging
progression on chest CT from coronavirus disease 2019 (covid-19)
patients. Aging (Albany NY). 12:6037–6048. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zheng F, Tang W, Li H, Huang YX, Xie YL
and Zhou ZG: Clinical characteristics of 161 cases of corona virus
disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci.
24:3404–3410. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ishiguro T, Kagiyama N, Uozumi R, Odashima
K, Takaku Y, Kurashima K, Morita S and Takayanagi N: Clinical
characteristics of influenza-associated pneumonia of adults:
Clinical features and factors contributing to severity and
mortality. Yale J Biol Med. 90:165–181. 2017.PubMed/NCBI
|
|
29
|
Liu SL, Wang SY, Sun YF, Jia QY, Yang CL,
Cai PJ, Li JY, Wang L and Chen Y: Expressions of SAA, CRP, and FERR
in different severities of COVID-19. Eur Rev Med Pharmacol Sci.
24:11386–11394. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
CAPMAS, Central Agency for Public
Mobilization and Statistics: 2021. Available from: https://www.capmas.gov.eg/.
|
|
31
|
Peckham H, De Gruijter NM, Raine C,
Radziszewska A, Ciurtin C, Wedderburn LR, Rosser EC, Webb K and
Deakin CT: Male sex identified by global COVID-19 meta-analysis as
a risk factor for death and ITU admission. Nat Commun. 9(11:
6317)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Giovino GA, Mirza SA, Samet JM, Gupta PC,
Jarvis MJ, Bhala N, Peto R, Zatonski W, Hsia J, Morton J, et al:
Tobacco use in 3 billion individuals from 16 countries: An analysis
of nationally representative cross-sectional household surveys.
Lancet. 380:668–679. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Loffredo CA, Radwan GN, Eltahlawy EM,
El-Setouhy M, Magder L and Hussein MH: Estimates of the prevalence
of tobacco smoking in Egypt. Open J Epidemiol. 5:129–135. 2015.
|
|
34
|
Spagnolo PA, Manson JAE and Joffe H: Sex
and gender differences in health: What the COVID-19 pandemic can
teach us. Ann Intern Med. 173:385–386. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Regitz-Zagrosek V: Sex and gender
differences in health. Science and society series on sex and
science. EMBO Rep. 13:596–603. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Singh S, Chowdhry M, Chatterjee A and Khan
A: Gender-based disparities in COVID-19: Clinical characteristics
and propensity matched analysis of outcomes. MedRxiv: May 12, 2020
(Epub ahead of print).
|
|
37
|
Abdullah M, Chai PS, Chong MY, Tohit ERM,
Ramasamy R, Pei CP and Vidyadaran S: Gender effect on in vitro
lymphocyte subset levels of healthy individuals. Cell Immunol.
272:214–219. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hewagama A, Patel D, Yarlagadda S,
Strickland FM and Richardson BC: Stronger inflammatory/cytotoxic
T-cell response in women identified by microarray analysis. Genes
Immun. 10:509–516. 2009.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Gal-Oz ST, Maier B, Yoshida H, Seddu K,
Elbaz N, Czysz C, Zuk O, Stranger BE, Ner-Gaon H and Shay T: ImmGen
report: Sexual dimorphism in the immune system transcriptome. Nat
Commun. 10(4295)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Klein SL and Flanagan KL: Sex differences
in immune responses. Nat Rev Immunol. 16:626–638. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Chen Q, Kong H, Qi X, Ding W, Ji N, Wu C,
Huang C, Wu W, Huang M, Wu W, et al: Carcinoembryonic antigen: A
potential biomarker to evaluate the severity and prognosis of
COVID-19. Front Med (Lausanne). 7(579543)2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li H, Xiang X, Ren H, Xu L, Zhao L, Chen
X, Long H, Wang Q and Wu Q: Serum amyloid A is a biomarker of
severe coronavirus disease and poor prognosis. J Infect.
80:646–655. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Behrens K and Alexander WS: Cytokine
control of megakaryopoiesis. Growth Factors. 36:89–103.
2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Connolly M, Rooney PR, Mcgarry T, Maratha
AX, Mccormick J, Miggin SM, Veale DJ and Fearon U: Acute serum
amyloid A is an endogenous TLR2 ligand that mediates inflammatory
and angiogenic mechanisms. Ann Rheum Dis. 75:1392–1398.
2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Sack GH: Serum amyloid A - A review. Mol
Med. 24(46)2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wakai M, Hayashi R, Tanaka S, Naito T,
Kumada J, Nomura M, Takigawa H, Oka S, Ueno Y, Ito M, et al: Serum
amyloid A is a better predictive biomarker of mucosal healing than
C-reactive protein in ulcerative colitis in clinical remission. BMC
Gastroenterol. 20(85)2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Liu C, Zhang Y, Shang Y, Fang C, He Q and
Xie L: Clinical values of common biomarkers for efficacy monitoring
of antibiotics in early onset neonatal sepsis. Transl Pediatr.
9:669–676. 2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yip TT, Chan JW, Cho WC, Yip TT, Wang Z,
Kwan TL, Law SC, Tsang D, Chan JK, Lee KC, et al: Protein chip
array profiling analysis in patients with severe acute respiratory
syndrome identified serum amyloid A protein as a biomarker
potentially useful in monitoring the extent of pneumonia. Clin
Chem. 51:47–55. 2005.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Zinellu A, Paliogiannis P, Carru C and
Mangoni AA: Serum amyloid A concentrations, COVID-19 severity and
mortality: An updated systematic review and meta-analysis. Int J
Infect Dis. 105:668–674. 2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Cheng L, Yang JZ, Bai WH, Li ZY, Sun LF,
Yan JJ, Zhou CL and Tang BP: Prognostic value of serum amyloid A in
patients with COVID-19. Infection. 48:715–722. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wei X, Su J, Yang K, Wei J, Wan H, Cao X,
Tan W and Wang H: Elevations of serum cancer biomarkers correlate
with severity of COVID-19. J Med Virol. 92:2036–2041.
2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yang C, Wang J, Liu J, Huang S and Xiong
B: Elevated carcinoembryonic antigen in patients with COVID-19
pneumonia. J Cancer Res Clin Oncol. 146:3385–3388. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
He G, Jiang Z, Xue S, Sun X and Wang W:
Expression of LDH and CEA in serum in the process of targeted
therapy of lung adenocarcinoma and the association between them and
prognosis. Oncol Lett. 17:4550–4556. 2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Mohr AM, Gould JJ, Kubik JL, Talmon GA,
Casey CA, Thomas P, Tuma DJ and McVicker BL: Enhanced colorectal
cancer metastases in the alcohol-injured liver. Clin Exp
Metastasis. 34:171–184. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Noguchi T, Yamamoto K, Moriyama G, Saito
Y, Kyoyama H, Mikami S, Ono R, Kobayashi T, Yamana K and Uematsu K:
Evaluation of serum levels of carcinoembryonic antigen in allergic
bronchopulmonary aspergillosis. J Nippon Med School. 80:404–409.
2013.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Abbona GC, Papotti M, Gugliotta P, Pecchio
F and Rapellino M: Immunohistochemical detection of
carcinoembryonic antigen (CEA) in non-neoplastic lung disease. Int
J Biol Markers. 8:240–243. 1993.PubMed/NCBI
|
|
59
|
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu
SC, Mou HM, Wang LH, Zhang HR, et al: A pathological report of
three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing
Li Xue Za Zhi:. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
60
|
Fox SE, Akmatbekov A, Harbert JL, Li G,
Brown JQ and Heide RS: Pulmonary and cardiac pathology in African
American patients with COVID-19: An autopsy series from New
Orleans. Lancet Respir Med. 8:681–686. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z
and Zhang Z: D-Dimer levels on admission to predict in-hospital
mortality in patients with Covid-19. J Thromb Haemost.
18:1324–1329. 2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Levi M and Van der Poll T: Coagulation and
sepsis. Thromb Res. 149:38–44. 2017.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Gattinoni L, Coppola S, Cressoni M, Busana
M, Rossi S and Chiumello D: COVID-19 does not lead to a ‘typical’
acute respiratory distress syndrome. Am J Respir Crit Care Med.
201:1299–1300. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Oudkerk M, Buller HR, Kuijpers D, van Es
N, Oudkerk SF, McLoud T, Gommers D, Dissel JV, Cate HT and van Beek
EJ: Diagnosis, prevention, and treatment of thromboembolic
complications in COVID-19: Report of the national institute for
public health of the Netherlands. Radiology. 297:E216–E222.
2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Tang N, Li D, Wang X and Sun Z: Abnormal
coagulation parameters are associated with poor prognosis in
patients with novel coronavirus pneumonia. J Thromb Haemost.
18:844–847. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu W, Tao ZW, Wang L, Yuan ML, Liu K,
Zhou L, Wei S, Deng Y, Liu J, Liu HG, et al: Analysis of factors
associated with disease outcomes in hospitalized patients with 2019
novel coronavirus disease. Chin Med J (Engl). 133:1032–1038.
2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Efstathiou SP, Pefanis AV, Tsiakou AG,
Skeva II, Tsioulos DI, Achimastos AD and Mountokalakis TD: Fever of
unknown origin: Discrimination between infectious and
non-infectious causes. Eur J Intern Med. 21:137–143.
2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Kell DB and Pretorius E: Serum ferritin is
an important inflammatory disease marker, as it is mainly a leakage
product from damaged cells. Metallomics. 6:748–773. 2014.PubMed/NCBI View Article : Google Scholar
|
